SE521084C2 - Förfarande för framställning av paroxetin-hydroklorid- anhydrat från ett paroxetin-hydroklorid-solvat - Google Patents

Förfarande för framställning av paroxetin-hydroklorid- anhydrat från ett paroxetin-hydroklorid-solvat

Info

Publication number
SE521084C2
SE521084C2 SE9600406A SE9600406A SE521084C2 SE 521084 C2 SE521084 C2 SE 521084C2 SE 9600406 A SE9600406 A SE 9600406A SE 9600406 A SE9600406 A SE 9600406A SE 521084 C2 SE521084 C2 SE 521084C2
Authority
SE
Sweden
Prior art keywords
paroxetine hydrochloride
solvate
propan
anhydrate
paroxetine
Prior art date
Application number
SE9600406A
Other languages
English (en)
Swedish (sv)
Other versions
SE9600406L (sv
SE9600406D0 (sv
Inventor
Victor Witold Jacewicz
Neal Ward
Original Assignee
Smithkline Beecham Plc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=27267578&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=SE521084(C2) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Priority claimed from GBGB9502297.6A external-priority patent/GB9502297D0/en
Priority claimed from GBGB9503112.6A external-priority patent/GB9503112D0/en
Priority claimed from GBGB9509807.5A external-priority patent/GB9509807D0/en
Application filed by Smithkline Beecham Plc filed Critical Smithkline Beecham Plc
Publication of SE9600406D0 publication Critical patent/SE9600406D0/xx
Publication of SE9600406L publication Critical patent/SE9600406L/xx
Publication of SE521084C2 publication Critical patent/SE521084C2/sv

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
    • C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
    • C07D405/12—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a chain containing hetero atoms as chain links
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/04—Centrally acting analgesics, e.g. opioids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/24—Antidepressants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/26—Psychostimulants, e.g. nicotine, cocaine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/04—Anorexiants; Antiobesity agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P39/00—General protective or antinoxious agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Engineering & Computer Science (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Neurosurgery (AREA)
  • Neurology (AREA)
  • Biomedical Technology (AREA)
  • Psychiatry (AREA)
  • Hematology (AREA)
  • Obesity (AREA)
  • Diabetes (AREA)
  • Pain & Pain Management (AREA)
  • Toxicology (AREA)
  • Child & Adolescent Psychology (AREA)
  • Hospice & Palliative Care (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
SE9600406A 1995-02-06 1996-02-05 Förfarande för framställning av paroxetin-hydroklorid- anhydrat från ett paroxetin-hydroklorid-solvat SE521084C2 (sv)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
GBGB9502297.6A GB9502297D0 (en) 1995-02-06 1995-02-06 Novel compound
GBGB9503112.6A GB9503112D0 (en) 1995-02-17 1995-02-17 Novel compound
GBGB9509807.5A GB9509807D0 (en) 1995-05-15 1995-05-15 Novel compounds

Publications (3)

Publication Number Publication Date
SE9600406D0 SE9600406D0 (sv) 1996-02-05
SE9600406L SE9600406L (sv) 1996-08-07
SE521084C2 true SE521084C2 (sv) 2003-09-30

Family

ID=27267578

Family Applications (1)

Application Number Title Priority Date Filing Date
SE9600406A SE521084C2 (sv) 1995-02-06 1996-02-05 Förfarande för framställning av paroxetin-hydroklorid- anhydrat från ett paroxetin-hydroklorid-solvat

Country Status (47)

Country Link
EP (3) EP1136490B1 (de)
JP (2) JP2915338B2 (de)
KR (1) KR100289885B1 (de)
CN (3) CN1090187C (de)
AR (2) AR001982A1 (de)
AT (1) AT407528B (de)
AU (2) AU4786496A (de)
BE (1) BE1009112A3 (de)
BG (1) BG62967B1 (de)
BR (1) BR9600534A (de)
CA (3) CA2210022C (de)
CH (3) CH689229A5 (de)
CZ (1) CZ297171B6 (de)
DE (3) DE69621777T2 (de)
DK (2) DK11996A (de)
DZ (1) DZ1989A1 (de)
ES (1) ES2114471B1 (de)
FI (3) FI111544B (de)
FR (1) FR2730232B1 (de)
GR (1) GR1002466B (de)
HK (1) HK59397A (de)
HU (1) HUP9600255A1 (de)
IE (1) IE80500B1 (de)
IL (1) IL117035A (de)
IT (1) IT1289532B1 (de)
LU (1) LU88711A1 (de)
LV (1) LV11618B (de)
MA (1) MA23802A1 (de)
MC (1) MC2411A1 (de)
MX (1) MX9600484A (de)
MY (1) MY132529A (de)
NL (1) NL1002248C2 (de)
NO (3) NO301009B1 (de)
NZ (1) NZ280943A (de)
OA (1) OA10261A (de)
PL (1) PL189247B1 (de)
PT (1) PT101827B (de)
RO (1) RO112426B1 (de)
RU (1) RU2125052C1 (de)
SE (1) SE521084C2 (de)
SG (1) SG43787A1 (de)
SI (2) SI9600036B (de)
SK (1) SK283608B6 (de)
TR (1) TR199600096A2 (de)
TW (1) TW503238B (de)
UA (1) UA49796C2 (de)
WO (1) WO1996024595A1 (de)

Families Citing this family (39)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP3882224B2 (ja) 1996-05-31 2007-02-14 旭硝子株式会社 パロキセチンの製造方法
EP1394160A1 (de) * 1996-06-13 2004-03-03 SUMIKA FINE CHEMICALS Co., Ltd. Verfahren zur Herstellung von kristallinem Paroxetin-Hydrochlorid
JP2000514653A (ja) * 1996-07-15 2000-11-07 スミスクライン・ビーチャム・パブリック・リミテッド・カンパニー 立体特異的分割のためのエステラーゼのスクリーニングおよびその使用
US6638948B1 (en) 1996-09-09 2003-10-28 Pentech Pharmaceuticals, Inc. Amorphous paroxetine composition
US5672612A (en) * 1996-09-09 1997-09-30 Pentech Pharmaceuticals, Inc. Amorphous paroxetine composition
EE03970B1 (et) 1997-06-10 2003-02-17 Synthon B.V. 4-fenüülpiperidiinühend, selle valmistamine ja kasutamine ning seda sisaldav ravim
DK0987256T3 (da) * 1997-08-08 2002-02-11 Aventis Pharma Gmbh Krystalform af N-(4-trifluormethylphenyl)-5-methylisoxazol-4-carboxylsyreamid
GB9726907D0 (en) * 1997-12-19 1998-02-18 Smithkline Beecham Plc Novel compounds
IL138390A0 (en) * 1998-03-16 2001-10-31 Smithkline Beecham Plc Crystalline form of paroxetine
GB9806312D0 (en) * 1998-03-24 1998-05-20 Smithkline Beecham Plc Novel formulations
AU2003200534B2 (en) * 1998-03-24 2004-12-02 Smithkline Beecham Plc Paroxetine compositions
US6699882B2 (en) 1998-03-24 2004-03-02 Smithkline Beecham P.L.C. Paroxetine compositions
JP3796351B2 (ja) 1998-04-13 2006-07-12 住友化学株式会社 パロキセチン塩酸塩無水和物の乾燥方法
GB9812941D0 (en) * 1998-06-16 1998-08-12 Smithkline Beecham Plc Method of treatment
CH689805A8 (fr) * 1998-07-02 2000-02-29 Smithkline Beecham Plc Méthanesulfonate de paroxétine, procédé pour sa préparation et compositions pharmaceutiques le contenant.
ES2138937B1 (es) 1998-07-07 2000-10-01 Medichem Sa Polimorfo de maleato de paroxetina y formulaciones farmaceuticas que lo contienen.
WO2000008017A1 (en) * 1998-08-07 2000-02-17 Smithkline Beecham Plc Process for the preparation of a non-crystalline anhydrate form of paroxetine hydrochloride
GB9824298D0 (en) * 1998-11-05 1998-12-30 Smithkline Beecham Plc Novel process
GB9826176D0 (en) * 1998-11-28 1999-01-20 Smithkline Beecham Plc Novel process
GB9826175D0 (en) * 1998-11-28 1999-01-20 Smithkline Beecham Plc Novel process
GB9826178D0 (en) * 1998-11-30 1999-01-20 Smithkline Beecham Plc Novel process
GB9826180D0 (en) * 1998-11-30 1999-01-20 Smithkline Beecham Plc Novel process
WO2000032594A1 (en) * 1998-11-30 2000-06-08 Smithkline Beecham Plc Mixed paroxetine propan-2-ol solvates
GB9826242D0 (en) * 1998-11-30 1999-01-20 Smithkline Beecham Plc Novel process
GB9826171D0 (en) * 1998-11-30 1999-01-20 Smithkline Beecham Plc Novel compounds
GB9828767D0 (en) * 1998-12-29 1999-02-17 Smithkline Beecham Plc Novel process
IT1308629B1 (it) * 1999-02-23 2002-01-09 Recordati Chem Pharm Processo per la produzione di paroxetina.
ATE311883T1 (de) * 1999-03-12 2005-12-15 Aesica Pharmaceuticals Ltd Stabile pharmazeutische anwendungsform für paroxetin-anhydrat
GB9914583D0 (en) * 1999-06-22 1999-08-25 Smithkline Beecham Plc Novel process
GB9914585D0 (en) * 1999-06-22 1999-08-25 Smithkline Beecham Plc Novel process
SE9902550D0 (sv) * 1999-07-02 1999-07-02 Astra Ab New crystalline forms
GB9919001D0 (en) * 1999-08-12 1999-10-13 Smithkline Beecham Plc Novel process
GB9923445D0 (en) * 1999-10-04 1999-12-08 Smithkline Beecham Plc Novel process
GB9923446D0 (en) * 1999-10-04 1999-12-08 Smithkline Beecham Plc Novel process
GB9923439D0 (en) * 1999-10-04 1999-12-08 Smithkline Beecham Plc Novel process
HU226912B1 (en) * 2000-04-07 2010-03-01 Richter Gedeon Nyrt New paroxetin salt and medicament containing it
AU2001286232A1 (en) * 2000-09-14 2002-03-26 Asahi Glass Company, Limited Process for producing paroxetine salt containing substantially no organic solvent
WO2003072104A1 (en) * 2002-02-22 2003-09-04 Teva Pharmaceutical Industries Ltd. Preparation of paroxetine involving novel intermediates
US7563930B2 (en) * 2005-11-22 2009-07-21 Teva Pharmaceutical Industries Ltd Crystal forms of Cinacalcet HCI and processes for their preparation

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1422263A (en) * 1973-01-30 1976-01-21 Ferrosan As 4-phenyl-piperidine compounds
GB8430581D0 (en) * 1984-12-04 1985-01-09 Ferrosan As Treatment
EP0223403B1 (de) * 1985-10-25 1993-08-04 Beecham Group Plc Piperidinderivat, seine Herstellung und seine Verwendung als Arzneimittel
US5017585A (en) * 1986-11-03 1991-05-21 Novo Nordisk A/S Method of treating calcium overload
GB8626936D0 (en) * 1986-11-11 1986-12-10 Ferrosan As Treatment
DK715988D0 (da) * 1988-12-22 1988-12-22 Ferrosan As Etherifikation og dealkylering af piperidin-derivater samt intermediater
DK716088D0 (da) * 1988-12-22 1988-12-22 Ferrosan As Reduktion af piperidin-dion-derivater samt intermediat
JPH06502854A (ja) * 1990-11-24 1994-03-31 ビーチャム・グループ・パブリック・リミテッド・カンパニー 老年痴呆、過食症、片頭痛または食欲不振の治療用のパロキセチンの使用
US5258517A (en) * 1992-08-06 1993-11-02 Sepracor, Inc. Method of preparing optically pure precursors of paroxetine
GB9325644D0 (en) * 1993-12-15 1994-02-16 Smithkline Beecham Plc Novel formulation

Also Published As

Publication number Publication date
CN1289496C (zh) 2006-12-13
AU4332896A (en) 1996-08-15
OA10261A (en) 1997-09-19
CA2211522C (en) 1999-12-07
AU701518C (en) 2006-12-07
FI960519L (fi) 1996-08-07
IL117035A (en) 2000-02-29
SI21923B (sl) 2006-12-31
EP0808314B1 (de) 2002-06-12
NO311519B1 (no) 2001-12-03
FR2730232B1 (fr) 1997-08-01
HUP9600255A1 (en) 1997-03-28
EP0808314A1 (de) 1997-11-26
MY132529A (en) 2007-10-31
SE9600406L (sv) 1996-08-07
NO301009B1 (no) 1997-09-01
CH688353A5 (de) 1997-08-15
IE960104A1 (en) 1996-08-07
CN1090187C (zh) 2002-09-04
DK11996A (da) 1996-08-07
DZ1989A1 (fr) 2002-10-15
IT1289532B1 (it) 1998-10-15
MX9600484A (es) 1997-01-31
PT101827A (pt) 1996-09-30
DE19603797C2 (de) 1998-11-12
CZ32096A3 (en) 1996-08-14
DE69621777T2 (de) 2003-01-02
ES2114471B1 (es) 1999-08-16
NZ280943A (en) 1997-01-29
JPH11228571A (ja) 1999-08-24
EP1136490A1 (de) 2001-09-26
CN1636993A (zh) 2005-07-13
AR001982A1 (es) 1998-01-07
CA2211522A1 (en) 1996-08-07
SI9600036B (sl) 2006-12-31
FI20030370L (fi) 2003-03-12
CN1143643A (zh) 1997-02-26
CA2168829C (en) 1997-12-16
MC2411A1 (fr) 1996-12-02
NO20015070D0 (no) 2001-10-18
CH689229A5 (de) 1998-12-31
AT407528B (de) 2001-04-25
ATA21096A (de) 2000-08-15
TW503238B (en) 2002-09-21
DK200100223A (de) 2001-02-12
AU701518B2 (en) 1999-01-28
RU2125052C1 (ru) 1999-01-20
NL1002248C2 (nl) 1996-09-11
CA2210023A1 (en) 1996-08-07
NO301009B3 (de) 2003-01-06
SK14396A3 (en) 1996-11-06
CN1310180A (zh) 2001-08-29
FI960519A0 (fi) 1996-02-05
LV11618A (lv) 1996-12-20
PL312646A1 (en) 1996-08-19
JP2915338B2 (ja) 1999-07-05
DE69621777D1 (de) 2002-07-18
SI9600036A (en) 1996-10-31
CA2210023C (en) 1999-02-09
BR9600534A (pt) 1997-05-13
CA2210022A1 (en) 1996-08-07
KR960031409A (ko) 1996-09-17
KR100289885B1 (ko) 2001-05-15
FR2730232A1 (fr) 1996-08-09
LV11618B (en) 1997-04-20
AU4786496A (en) 1996-08-27
BG100333A (bg) 1996-08-30
SK283608B6 (sk) 2003-10-07
NO960472L (no) 1996-08-07
FI111544B (fi) 2003-08-15
FI20030370A7 (fi) 2003-03-12
SE9600406D0 (sv) 1996-02-05
MA23802A1 (fr) 1996-10-01
DE19603797A1 (de) 1996-08-14
BG62967B1 (bg) 2000-12-29
DE69631298D1 (de) 2004-02-12
IL117035A0 (en) 1996-09-12
ES2114471A1 (es) 1998-05-16
ITMI960203A1 (it) 1997-08-05
NL1002248A1 (nl) 1996-08-06
FI20030162A7 (fi) 2003-02-03
CA2168829A1 (en) 1996-08-07
NO20015070L (no) 1996-08-07
NO960472D0 (no) 1996-02-05
SI21923A (sl) 2006-06-30
SG43787A1 (en) 1997-11-14
GR1002466B (el) 1996-11-06
CZ297171B6 (cs) 2006-09-13
NO970939D0 (no) 1997-02-28
PL189247B1 (pl) 2005-07-29
FI20030162L (fi) 2003-02-03
TR199600096A2 (tr) 1996-08-21
JPH08245620A (ja) 1996-09-24
IE80500B1 (en) 1998-08-12
UA49796C2 (uk) 2002-10-15
HU9600255D0 (en) 1996-03-28
DE69631298T2 (de) 2004-11-18
EP1136490B1 (de) 2004-01-07
WO1996024595A1 (en) 1996-08-15
LU88711A1 (fr) 1996-08-23
ITMI960203A0 (de) 1996-02-05
BE1009112A3 (fr) 1996-11-05
CN1216055C (zh) 2005-08-24
NO970939L (no) 1996-08-07
PT101827B (pt) 1997-08-29
RO112426B1 (ro) 1997-09-30
AR036856A2 (es) 2004-10-06
MX198371B (de) 2000-08-29
HK59397A (en) 1997-05-16
EP1378508A1 (de) 2004-01-07
CA2210022C (en) 2005-09-13
CH689804A5 (de) 1999-11-30

Similar Documents

Publication Publication Date Title
KR100289885B1 (ko) 파로제틴 히드로클로리드 무수물, 이의 제조방법 및 이를 함유하는 제약 조성물
US6133289A (en) Paroxetine hydrochloride form A or C
CA2210023E (en) Process for the preparation of paroxetine hydrochloride anhydrate form a.
KR102858471B1 (ko) Lta4h 저해제의 결정질 형태
CN113861184B (zh) 2-(取代的嘧啶基)噻唑甲酰胺化合物的磷酸盐及其用途
LT4100B (en) Paroxetine hydrochloride anhydrate and process for preparing thereof
CA2211521A1 (en) Novel paroxetine hydrochlorine anhydrate forms
JP2002531452A (ja) 混合パロキセチンプロパン−２−オール溶媒和物

Legal Events

Date Code Title Description
CANC Patent cancelled, revoked after opposition
NUG Patent has lapsed